Friess Associates’s Xylem XYL Stock Holding History

Friess Associates’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-360,000	Closed	-$16.1M	–	160
2016 Q2	$16.1M	Buy	+360,000	New	+$15.6M	1.64%	26

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Friess Associates's XYL Position: Q3 2016 in Review

Friess Associates sold out of Xylem (XYL) in Q3 2016, closing a stake of 360,000 shares — an estimated $16.1M sold.

Friess Associates first reported a position in XYL in Q2 2016 and held it in 1 quarter. The position peaked at $16.1M in Q2 2016. 521 funds tracked by Wall St. Rank hold XYL as of Q3 2016.

Friess Associates reported no remaining Xylem position as of Q3 2016 after selling out during the quarter.
Friess Associates sold 360,000 Xylem shares in Q3 2016, an estimated $16.1M.
Friess Associates first reported a position in Xylem in Q2 2016 and held it in 1 quarter.
Friess Associates's Xylem position peaked at $16.1M in Q2 2016.
521 funds tracked by Wall St. Rank held Xylem as of Q3 2016.

Based on Friess Associates's 13F filing for Q3 2016, filed 14 Nov 2016.